Health Universe, an enterprise AI platform focused on automating complex healthcare workflows, announced it has raised $6 million in seed funding, bringing its total funding to $9.5 million. The round was led by Kleiner Perkins and follows a 2023 pre-seed backed by Susa Ventures, Twelve Below, and Oncology Ventures. The company plans to use the new capital to accelerate adoption across academic medical centers, health systems, and life sciences organizations.
The San Francisco-based company is building what it describes as an AI infrastructure layer for healthcare, enabling organizations to deploy auditable and compliant AI agents. Its platform is designed to address mounting pressures in healthcare, including clinician burnout, administrative overload, and lengthy clinical trial timelines that often stretch nearly eight months before enrolling a patient.
Health Universe’s platform functions as an AI workflow engine that allows organizations to build, deploy, and govern autonomous and human-in-the-loop agents within a HIPAA-compliant environment. The system includes several components: Navigator for managing agents across patient records, Explorer for population-level analysis, and Observer for monitoring agent performance, costs, and risks.
The company has also developed specialized agents for oncology and clinical trials. Its oncology agents convert fragmented medical records into structured summaries covering diagnosis, staging, biomarkers, and treatment history, significantly reducing manual chart review time. Its clinical trial agents can generate full trial protocols from brief summaries and automate submissions and regulatory workflows.
In less than a year since launching its Navigator platform, Health Universe has processed over 170 million clinical documents. Early deployments have shown measurable impact. At Duke Clinical Research Institute, its Project Loom initiative accelerated clinical trial setup by 30 to 40 times, reducing timelines from six to nine months to approximately seven and a half days, while delivering 93% time savings across key tasks and 10 times faster document processing.
Health Universe has also emphasized regulatory readiness as a key differentiator. The platform is ONC B.11 certified, participates in the Trusted Exchange Framework and Common Agreement network, is SOC 2 Type II compliant, and is fully HIPAA-compliant. The company says these certifications and infrastructure typically take competitors 12 to 18 months and significant capital to achieve.
Looking ahead, the company is building an Agent-to-Agent marketplace designed to enable healthcare AI systems to securely exchange data and coordinate workflows across organizations.
KEY QUOTES:
“Healthcare doesn’t need another chatbot. It needs AI systems that are traceable, compliant, and built for real clinical workflows. Our infrastructure allows organizations to deploy agents that solve high-priority use cases quickly, usually in a matter of days or weeks, not months or years. And we provide the security, inspectability, and auditability that academic medical centers and healthcare stakeholders require. This new funding allows us to scale these capabilities and bring trusted AI agents and models to more institutions and health systems across the country.”
Dan Caron, Founder And CEO, Health Universe
“AI is already proving transformative in healthcare, but trust, security, and compliance are non-negotiable. Health Universe has built the rare combination of technical sophistication and regulatory readiness required for academic medicine. We believe they are defining the agentic layer for healthcare.”
Annie Case, Kleiner Perkins
